Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas

Australasian Journal of Dermatology, EarlyView.

Source: Australasian Journal of Dermatology - April 19, 2018 Category: Dermatology Authors: Cathy Yunjia Zhao , Pablo Fern ández‐Peñas Source Type: research